Anticipated Shortage

APO-CAPTO TAB 100MG

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-CAPTO TAB 100MG in Canada?

A shortage of APO-CAPTO TAB 100MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated June 15, 2026), but it has not started yet.

Why is APO-CAPTO TAB 100MG not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-CAPTO TAB 100MG be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file6 products

Affected strength100MG

Last updated2026-06-15

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

CAPTOPRIL-100 TAB 100MG

PRO DOC LIMITEE

100MG · DIN 01910388

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

CAPOTEN TAB 100MG

BRISTOL-MYERS SQUIBB CANADA

100MG · DIN 00546305

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MYLAN-CAPTOPRIL

MYLAN PHARMACEUTICALS ULC

100MG · DIN 02163594

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

RATIO-CAPTOPRIL TAB 100MG

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

100MG · DIN 00851655

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

CAPOTEN TAB 12.5MG

BRISTOL-MYERS SQUIBB CANADA

12.5MG · DIN 00695661

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

CAPOTEN TAB 25MG

BRISTOL-MYERS SQUIBB CANADA

25MG · DIN 00546283

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

00893625

Strength

100MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

CAPTOPRIL

See all CAPTOPRIL products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-06-15

Anticipated Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244